Long-Term Behavioral Recovery in Parkinsonian Rats by an HSV Vector Expressing Tyrosine Hydroxylase

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Science

• Publication date

  1994-11-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/science.266.5189.1399PMID 7669103PMCID PMC2638002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tyrosine hydroxylase-immunoreactive intrinsic neurons in the rat cerebral cortex

  2004cited by this paper
• The use of a retroviral vector to identify foetal striatal neurones transplanted into the adult striatum

  2004cited by this paper
• Long-term correction of rat model of Parkinson's disease by gene therapy

  1996cited by this paper
• An HSV‐1 Vector Expressing Tyrosine Hydroxylase Causes Production and Release of l‐DOPA from Cultured Rat Striatal Cells

  1995cited by this paper
• Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain.

  1994cited by this paper
• Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism.

  1994cited by this paper
• A protein tyrosine phosphatase expressed within dopaminoceptive neurons of the basal ganglia and related structures

  1993cited by this paper
• Long-term correction of rat model of Parkinson's disease by gene therapy

  1993cited by this paper
• Microdialysis Monitoring of 3,4‐Dihydroxyphenylalanine Accumulation After Decarboxylase Inhibition: A Means to Estimate In Vivo Changes in Tyrosine Hydroxylase Activity of the Rat Locus Ceruleus

  1993cited by this paper
• Four isoforms of tyrosine hydroxylase are expressed in human brain.

  1993cited by this paper
• Clearance of Exogenous Dopamine in Rat Dorsal Striatum and Nucleus Accumbens: Role of Metabolism and Effects of Locally Applied Uptake Inhibitors

  1993cited by this paper
• Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease.

  1992cited by this paper
• Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia.

  1992cited by this paper
• Biochemical and behavioral recovery in a rodent model of Parkinson's disease following stereotactic implantation of dopamine-containing liposomes.

  1992cited by this paper
• Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease.

  1992cited by this paper
• Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

  1992cited by this paper
• Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum.

  1992cited by this paper
• Gene Expression of Aromatic l‐Amino Acid Decarboxylase in Cultured Rat Glial Cells

  1992cited by this paper
• Infection of cultured striatal neurons with a defective HSV-1 vector: implications for gene therapy.

  1991cited by this paper
• Genetically modified cells: applications for intracerebral grafting.

  1991cited by this paper
• A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons.

  1990cited by this paper
• Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues.

  1990cited by this paper
• Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase.

  1990cited by this paper
• In vivo release of dopa and dopamine from genetically engineered cells grafted to the denervated rat striatum.

  1990cited by this paper
• An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.

  1990cited by this paper
• Dopamine cell replacement: Parkinson's disease.

  1990cited by this paper
• Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease.

  1990cited by this paper
• Use of Microdialysis for Monitoring Tyrosine Hydroxylase Activity in the Brain of Conscious Rats

  1990cited by this paper
• Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease.

  1989cited by this paper
• Tyrosine hydroxylase-like immunoreactive neurons in the striatum of the rat.

  1989cited by this paper
• A 6-hydroxydopamine-induced selective parkinsonian rat model.

  1989cited by this paper
• Striatal neurons with aromatic L-amino acid decarboxylase-like immunoreactivity in the rat.

  1989cited by this paper
• The organization of the projection from the cerebral cortex to the striatum in the rat.

  1989cited by this paper
• Fetal dopamine neural grafts: extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys.

  1988cited by this paper
• A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics

  1987cited by this paper
• Morphology and synaptic connections of crossed corticostriatal neurons in the rat

  1987cited by this paper
• Biochemical and Behavioral Correction of MPTP Parkinson‐like Syndrome by Fetal Cell Transplantation a

  1987cited by this paper
• The organization and collateralization of corticostriate neurones in the motor and sensory cortex of the rat brain.

  1987cited by this paper
• First-strand cDNA synthesis primed with oligo(dT).

  1987cited by this paper
• RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons.

  1987cited by this paper
• Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5' alternative splice sites responsible for multiple mRNAs.

  1987cited by this paper
• Primate neostriatal neurons containing tyrosine hydroxylase: immunohistochemical evidence.

  1987cited by this paper
• Organization and evolution of the rat tyrosine hydroxylase gene.

  1987cited by this paper
• Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine.

  1986cited by this paper
• Developmental potential of quail dorsal root ganglion cells analyzed in vitro and in vivo

  1986cited by this paper
• Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1.

  1986cited by this paper
• Differential activation of hybrid genes containing herpes simplex virus immediate-early or delayed-early promoters after superinfection of stable DNA-transfected cell lines

  1985cited by this paper
• The immunocytochemical detection of Herpes simplex virus in cervical smears—a valuable technique for routine use

  1984cited by this paper
• The nucleotide sequence of a rat 18 S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18 S ribosomal ribonucleic acid.

  1984cited by this paper
• Demonstration of a pallidostriatal pathway by retrograde transport of HRP-labeled lectin.

  1981cited by this paper
• Latency competence of thirteen HSV-1 temperature-sensitive mutants.

  1980cited by this paper
• Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: Long‐term behavioral, biochemical, and histochemical studies

  1980cited by this paper
• Treatment of parkinsonism with levodopa.

  1969cited by this paper

• Glial Cell Reprogramming in Ischemic Stroke: A Review of Recent Advancements and Translational Challenges

  2025cites this paper
• Development of In Vitro Parkinson's Disease Model Mediated by MPP+ and α‐Synuclein Using Wharton's Jelly Mesenchymal Stem Cells

  2025cites this paper
• Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson’s disease mouse model through activating GHS-R1a/D2R heterodimers

  2023cites this paper
• DGHNE: network enhancement-based method in identifying disease-causing genes through a heterogeneous biomedical network

  2022cites this paper
• Whole-Brain Afferent Inputs to the Caudate Nucleus, Putamen, and Accumbens Nucleus in the Tree Shrew Striatum

  2021cites this paper
• Progresses in Gene Therapy of Neurodegenerative

  2019cites this paper
• Repairing the Brain: Gene Therapy

  2018cites this paper
• The Effect of Recombinant Tyrosine Hydroxylase Expression on the Neurogenic Differentiation Potency of Mesenchymal Stem Cells

  2018cites this paper
• Uptake of DNA by cancer cells without a transfection reagent

  2017cites this paper
• Regenerative Medicine in the Central Nervous System: Stem Cell-Based Cell- and Gene-Therapy

  2016cites this paper
• GAD Gene Therapy for Parkinson’s Disease

  2016cites this paper
• Engineering Stem Cells for Biomedical Applications

  2016cites this paper
• Human Neural Stem Cell-Based Cell- and Gene-Therapy for Neurological Diseases

  2014cites this paper
• Herpes Simplex Virus 1 (HSV-1)-Based Vectors

  2014cites this paper
• Cationic amino acid based lipids as effective nonviral gene delivery vectors for primary cultured neurons.

  2013cites this paper
• Investigational surgical therapies

  2013cites this paper
• Subthalamic hGAD65 Gene Therapy and Striatum TH Gene Transfer in a Parkinson’s Disease Rat Model

  2013influential citation
• Liposomes for brain delivery

  2013cites this paper
• A synopsis on the role of tyrosine hydroxylase in Parkinson's disease.

  2012cites this paper
• Herpes simplex virus type 1-based amplicon vectors for fundamental research in neurosciences and gene therapy of neurological diseases.

  2012cites this paper
• Cellular Therapies for Huntington’s Disease

  2012influential citation
• Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications

  2012cites this paper
• Viral Vectors for Gene Transfer

  2012cites this paper
• Behavioral improvement in MPTP-treated nonhuman primates in the HALLWAY task after transfer of TH cDNA to host astrocytes.

  2012cites this paper
• Chapter 117 – Molecular Therapies for Movement Disorders

  2012cites this paper
• A 16 bp upstream sequence from the rat tyrosine hydroxylase promoter supports long-term expression from a neurofilament promoter, in a helper virus-free HSV-1 vector system.

  2011cites this paper
• The effect of lentivirus-mediated TH and GDNF genetic engineering mesenchymal stem cells on Parkinson’s disease rat model

  2011cites this paper
• Therapeutic gene transfer to the nervous system using viral vectors

  2011cites this paper
• Herpes simplex virus type 1-based amplicon vectors for fundamental research 3 in neurosciences and gene therapy of neurological diseases

  2011cites this paper
• An Update on Gene Therapy in Parkinson’s Disease

  2011cites this paper
• [Gene therapy in Parkinson disease: a promising future treatment?].

  2011cites this paper
• Regenerative Medicine in the Central Nervous System: Stem Cell-Based Gene-Therapy

  2011cites this paper
• Human neuroblastoma cells transfected with tyrosine hydroxylase gain increased resistance to methylmercury-induced cell death.

  2010cites this paper
• Gene therapy for Parkinson's disease

  2010cites this paper
• Expression of tyrosine hydroxylase increases the resistance of human neuroblastoma cells to oxidative insults.

  2010cites this paper
• Gene therapy to improve pancreatic islet transplantation for Type 1 diabetes mellitus.

  2010cites this paper
• Constitutive and Inducible Innate Responses in Cells Infected by HSV-1-Derived Amplicon Vectors

  2010cites this paper
• Gene therapy for dopamine replacement.

  2010cites this paper
• Constitutive and Inducible Innate Responses in Cells Infected by HSV-1-Derived Amplicon Vectors.

  2010cites this paper
• Stem cell‐based cell therapy in neurological diseases: A review

  2009cites this paper
• Versatile Somatic Gene Transfer for Modeling Neurodegenerative Diseases

  2009cites this paper
• Optimization of continuous in vivo DOPA production and studies on ectopic DA synthesis using rAAV5 vectors in Parkinsonian rats

  2009cites this paper
• HSV-1-derived amplicon vectors: recent technological improvements and remaining difficulties--a review.

  2009cites this paper
• Quantitative characterization of cell transduction by HSV-1 amplicons using flow cytometry and real-time PCR.

  2009cites this paper
• Long-term genetic modification of the ocular outflow tract and the retinal pigment epithelium with feline immunodeficiency viral vectors

  2008cites this paper
• Advances in gene therapy for movement disorders

  2008cites this paper
• Preclinical development of gene therapy for Parkinson's disease.

  2008cites this paper
• Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice.

  2008cites this paper
• Concepts in genetic medicine

  2008cites this paper
• Future of cell and gene therapies for Parkinson's disease

  2008cites this paper
• HSV as a vector in vaccine development and gene therapy

  2008cites this paper
• Regulatable promoters and gene therapy for Parkinson's disease: is the only thing to fear, fear itself?

  2008cites this paper
• HSV as a vector in vaccine development and gene therapy.

  2008cites this paper
• The Future of Deep Brain Stimulation

  2008cites this paper
• Investigation of gene and cellular therapies to cure maple syrup urine disease (MSUD) in a genetically engineered mouse model

  2008cites this paper
• STEM CELL THERAPIES FOR PARKINSON'S DISEASE

  2008cites this paper
• THE DOPAMINERGIC NIGROSTRIATAL SYSTEMAND PARKINSON'S DISEASE: MOLECULAR EVENTSIN DEVELOPMENT, DISEASE, AND CELL DEATH, AND NEW THERAPEUTIC STRATEGIES

  2007cites this paper
• [Gene therapy for Parkinson's disease].

  2007cites this paper
• Nonviral Approaches for Neuronal Delivery of Nucleic Acids

  2007cites this paper
• Role of in vivo imaging of the central nervous system for developing novel drugs.

  2007cites this paper
• Dévelappement de vecteurs lentiviraux non-intergratifs en vue du transfert de gènes dans le système nerveux central.

  2007cites this paper
• Genetically engineered human neural stem cells for brain repair in neurological diseases.

  2007cites this paper
• HSV-1 amplicon vectors

  2007cites this paper
• In vivo gene therapy as a potential treatment for Parkinson's disease

  2006cites this paper
• Gene transfer to the nerve system using HSV-1-derived amplicon vectors.

  2006cites this paper
• Convection-Enhanced Delivery of Adeno-Associated Virus Type 2 (AAV2) into the Striatum and Transport of AAV2 Within Monkey Brain

  2006cites this paper
• Effects of overexpression of Sim2 on spatial memory and expression of synapsin I in rat hippocampus

  2006cites this paper
• Gene technology based therapies in the brain.

  2006cites this paper
• Regulatable gene expression systems for gene therapy.

  2006cites this paper
• Cell-Based Therapy for Huntington’s Disease

  2006cites this paper
• Progress and development in Parkinson disease therapy

  2006cites this paper
• Gene Therapy to the Nervous System

  2006cites this paper
• Non-Invasive Gene Therapy of Experimental Parkinson's Disease

  2006cites this paper
• Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease

  2006cites this paper
• Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson’s disease

  2006cites this paper
• CHAPTER 8 – Gene Therapy for Parkinson's Disease

  2006cites this paper
• Gene Therapy Applications for Parkinson’s Disease

  2006cites this paper
• PET as a Tool in Multimodality Imaging of Gene Expression and Therapy

  2005cites this paper
• [Cell therapy and other neuroregenerative strategies in Parkinson's disease (II)].

  2005cites this paper
• Human gene therapy and imaging in neurological diseases

  2005cites this paper
• Use of herpes virus amplicon vectors to study brain disorders.

  2005cites this paper
• Gene Transfer to the Central Nervous System: Current State of the Art of the Viral Vectors

  2005cites this paper
• HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy.

  2005cites this paper
• HSV-1-based amplicon vectors: design and applications

  2005cites this paper
• In vivo gene transfer to the brain cortex using a single injection of HSV-1 vector into the medial septum.

  2005cites this paper
• Regulatable gene expression systems for gene therapy applications: progress and future challenges.

  2005cites this paper
• Brain Transplantation of Neural Stem Cells Cotransduced with Tyrosine Hydroxylase and GTP Cyclohydrolase 1 in Parkinsonian Rats

  2005cites this paper
• Modifying xenogeneic immune recognition and engraftment by genetic engineering

  2005cites this paper
• Gene therapy in the central nervous system

  2005cites this paper
• Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease.

  2005cites this paper
• Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease.

  2005cites this paper
• Hypotheses and Translation into Neurosurgery Practice

  2004cites this paper
• Transduction Profiles of Recombinant Adeno-Associated Virus Vectors Derived from Serotypes 2 and 5 in the Nigrostriatal System of Rats

  2004cites this paper
• Novel Therapeutic Approaches for High-Grade Gliomas

  2004cites this paper
• A preproenkephalin—Neurofilament chimeric promoter in a helper virus-free herpes simplex virus vector enhances long-term expression in the rat striatum

  2004cites this paper
• The clinical potential of antiepileptic gene therapy

  2004cites this paper
• Herpes simplex virus‐based vectors

  2004cites this paper
• Functional expression of ATM gene carried by HSV amplicon vector in vitro and in vivo

  2004cites this paper
• Gene therapy for Parkinson's disease

  2004cites this paper
• Human neural stem cells genetically modified for brain repair in neurological disorders

  2004cites this paper